The Zepbound label sums it up as greater loss of fat than of lean mass.2
What the Zepbound scans showed
In SURMOUNT-1, 160 people had DXA scans at the start and at week 72, 124 on tirzepatide and 36 on placebo. On tirzepatide, lean mass fell by 10.9% and fat mass by 33.9%; on placebo, by 2.6% and 8.2%. In kilograms, the average was 15.9 kg of fat and 5.6 kg of lean tissue, against 3.6 kg and 1.2 kg on placebo. That is where the split of 74% fat and 26% lean tissue comes from.1
By age, sex, dose and amount lost
The study divided the people on tirzepatide into groups and worked out the share of the weight lost that was lean tissue in each:1
- Age: 26% under 50, 25% from 50 to 64, and 24% at 65 and over.
- Sex: 25% for women and 27% for men.
- Dose: 25% on 5 mg, 28% on 10 mg and 25% on 15 mg.
- Amount lost: 30% for those who lost 15.3 kg or less, 27% for 15.3 to 25.9 kg, and 24% for more than 25.9 kg.
Every group fell between 24% and 30%. The groups are small, since 124 people were split many ways, but the result for older adults, the group people worry about most, was no worse than for younger ones.
What the Wegovy scans showed
In the STEP 1 scan study of semaglutide, lean mass fell by 9.7%, yet lean tissue's share of total body weight rose by 3 percentage points from 53.9%, while the share of fat fell by 3.5 points. People ended up with less lean tissue and a leaner body composition at the same time.3 The 2025 nutrition advisory gives the Wegovy averages as 8.3 kg of fat and 5.3 kg of lean tissue.4
Muscle itself, by MRI
A DXA scan cannot tell muscle from the rest of the lean tissue; MRI can. In the SURPASS-3 MRI substudy of tirzepatide in type 2 diabetes, 246 people, 190 of them on tirzepatide, had a thigh MRI at the start and after 52 weeks. Thigh muscle volume fell by 0.64 litres. The researchers compared that with repeat scans of 2,942 people in the UK Biobank, which show how much muscle usually changes with a given weight change. The loss on tirzepatide matched that expectation, with a difference of 0.04 litres that was not statistically clear. The fat inside the muscle fell by 0.36 percentage points, 0.42 points more than the weight loss alone would predict.5
What helps keep lean mass
The 2025 joint advisory from four medical societies says resistance training, alone or mixed with aerobic exercise, is well established to help preserve lean mass during weight loss, while aerobic activity alone does less. It adds that how much lean mass is lost also depends on how hard calories are cut, how fast the weight comes off, and whether strength training is done. It names the people for whom low protein and muscle loss are a greater concern: older adults, women around or after menopause, men with lower testosterone, and anyone sedentary or not doing strength training.4 Our page on protein on a GLP-1 covers the protein side.
Sources
- Look M, Dunn JP, Kushner RF, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes Obes Metab 2025;27:2720-2729. doi:10.1111/dom.16275
- ZEPBOUND (tirzepatide) prescribing information, NDA 217806/S-041, revised August 2026. U.S. Food and Drug Administration; section 12.2. accessdata.fda.gov
- Wilding J, Batterham R, Calanna S, et al. Impact of semaglutide on body composition in adults with overweight or obesity: exploratory analysis of the STEP 1 study. J Endocr Soc 2021;5(Suppl 1):A16-A17. PMC8089287
- Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity (Silver Spring) 2025;33:1475-1503. doi:10.1002/oby.24336
- Sattar N, Neeland IJ, Dahlqvist Leinhard O, et al. Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial. Lancet Diabetes Endocrinol 2025;13:482-493. doi:10.1016/S2213-8587(25)00027-0
Related analyses
Muscle loss on Zepbound and Wegovy: how much of the weight lost is fat, and how much is muscle
How much protein to eat on Zepbound or Wegovy: the targets, calculated for your weight
What to eat on a GLP-1: the priorities of four medical societies, with a day you can build
Zepbound plateau: when weight loss slows, why, and what the trials show
Log strength sessions and protein next to your weight, the two things the advisory asks for.
Open Dose Insider